Bond Gilead Biosciences Inc 2.8% ( US375558BT99 ) in USD
| Issuer | Gilead Biosciences Inc |
| Market price | |
| Country | United States
|
| ISIN code |
US375558BT99 ( in USD )
|
| Interest rate | 2.8% per year ( payment 2 times a year) |
| Maturity | 30/09/2050 |
|
Prospectus brochure in PDF format is unavailable at this time We will provide it as soon as possible |
|
| Minimal amount | 1 000 USD |
| Total amount | 1 500 000 000 USD |
| Cusip | 375558BT9 |
| Standard & Poor's ( S&P ) rating | A- ( Upper medium grade - Investment-grade ) |
| Moody's rating | A3 ( Upper medium grade - Investment-grade ) |
| Next Coupon | 01/04/2026 ( In 53 days ) |
| Detailed description |
Gilead Sciences, Inc. is a biopharmaceutical company that discovers, develops, and commercializes innovative therapeutics in areas of unmet medical need, primarily focusing on HIV/AIDS, hepatitis B and C, and oncology. The Bond issued by Gilead Biosciences Inc ( United States ) , in USD, with the ISIN code US375558BT99, pays a coupon of 2.8% per year. The coupons are paid 2 times per year and the Bond maturity is 30/09/2050 The Bond issued by Gilead Biosciences Inc ( United States ) , in USD, with the ISIN code US375558BT99, was rated A3 ( Upper medium grade - Investment-grade ) by Moody's credit rating agency. The Bond issued by Gilead Biosciences Inc ( United States ) , in USD, with the ISIN code US375558BT99, was rated A- ( Upper medium grade - Investment-grade ) by Standard & Poor's ( S&P ) credit rating agency. |
Français
Italiano
United States